DOES VERAPAMIL LIMIT MYOCARDIAL INFARCT SIZE IN A HEART DEFICIENT IN XANTHINE OXIDASE?
- 1 November 1990
- journal article
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 17 (11) , 769-779
- https://doi.org/10.1111/j.1440-1681.1990.tb01279.x
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Influence of Allopurinol Plus Verapamil Treatment on Myocardial Tissue Necrosis During Permanent Coronary Occlusion in Canine Hearts with Small InfarctsJournal of Cardiovascular Pharmacology, 1989
- Collateral perfusion of ischemic myocardium is inversely related to the size of the ischemic zoneBasic Research in Cardiology, 1988
- Protection afforded by allopurinol in the first 24 hours of coronary occlusion is diminished after 48 hoursFree Radical Biology & Medicine, 1988
- Xanthine oxidase is not a source of free radicals in the ischemic rabbit heartJournal of Molecular and Cellular Cardiology, 1987
- Effects of calcium antagonists on infarcting myocardiumThe American Journal of Cardiology, 1987
- Xanthine oxidase as a source of free radical damage in myocardial ischemiaJournal of Molecular and Cellular Cardiology, 1985
- Verapamil in acute myocardial infarctionThe American Journal of Cardiology, 1984
- Reduction of creatine kinase and creatine kinase-MB indexes of infarct size by intravenous verapamilThe American Journal of Cardiology, 1984
- Preservation of high-energy phosphates by verapamil in reperfused myocardium.Circulation, 1984
- Simultaneous determination of verapamil and its seven metabolites by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1981